New York, NY (PRWEB) July 22, 2013
The Mount Sinai Medical Center has named Jean-Frédéric Colombel, MD, as the Director of The Leona M. and Harry B. Helmsley Charitable Trust Inflammatory Bowel Disease Center, which is scheduled to open in 2014. Dr. Colombel also recently joined the faculty of the Icahn School of Medicine at Mount Sinai as Professor of Medicine, Gastroenterology.
“Dr. Colombel is an internationally-renowned clinician and researcher in inflammatory bowel disease and gastroenterology,” said Bruce Sands, MD, Professor of Medicine, Gastroenterology and Chief of the Henry D. Janowitz Division of Gastroenterology at the Icahn School of Medicine. “He will lead a team of clinicians and researchers in a fully integrated, state-of-the-art facility to provide comprehensive IBD diagnostics and treatments for adults and children and to advance translational IBD research.”
Dr. Colombel is best known for his participation in the identification of NOD2 as a susceptibility gene for Crohn’s disease, and the identification of a new subtype of Escherichia coli associated with Crohn’s disease, as well as the development of the Anti-Saccharomyces Cerevisiae Antibody (ASCA) test, which remains the most sensitive and specific marker for Crohn’s disease. He has authored or coauthored more than 500 peer-reviewed articles, books, and book chapters on IBD.
Most recently, he was Professor of Hepatogastroenterology at Centre Hospitalier Universitaire de Lille in Lille, France, and President of the European Crohn’s and Colitis Organization.
The Center will offer patients a collaborative team of experts in gastroenterology, clinical immunology, nutrition, pathology, psychology, radiology, colorectal and laparoscopic surgery, and genetics and genomics. Its Young Adult IBD Transitional Program will assure patients a seamless transition from pediatric to adult gastroenterologists.
The Center’s s
Copyright©2012 Vocus, Inc.
All rights reserved